Biolife Solutions (BLFS) Non-Current Debt (2010 - 2026)

Biolife Solutions (BLFS) has reported Non-Current Debt for 13 consecutive years, with $2.5 million the latest figure, recorded in Q1 2026.

• On a quarterly basis, Non-Current Debt fell 80.7% year-over-year to $2.5 million in Q1 2026; TTM through Mar 2026 was $2.5 million, a 80.7% decrease from a year earlier, with the FY2025 full-year figure at $5.0 million, down 68.65% from the prior year.
• Non-Current Debt was $2.5 million for Q1 2026 at Biolife Solutions, down from $5.0 million in the prior quarter.
• Over five years, Non-Current Debt peaked at $26.3 million in Q3 2022 and troughed at $2.5 million in Q1 2026.
• A 5-year average of $16.8 million and a median of $20.1 million in 2024 frame the typical range for Non-Current Debt.
• Across the five-year window, Non-Current Debt surged 650.0% in 2022 and sank 80.7% in 2026, its largest moves.
• Over 5 years, Non-Current Debt stood at $25.6 million in 2022, then decreased by 6.88% to $23.8 million in 2023, then sank by 33.15% to $15.9 million in 2024, then plunged by 68.65% to $5.0 million in 2025, then plunged by 49.99% to $2.5 million in 2026.
• The last three Non-Current Debt figures came in at $2.5 million (Q1 2026), $5.0 million (Q4 2025), and $7.5 million (Q3 2025), per Business Quant data.